Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer
- Author
- GEMMA, A1 ; KUDOH, S1 ; YOSHIMURA, A1 ; ONO, Y1 ; TAKENAKA, K1 ; HAYASHIHARA, K1 ; HINO, M1 ; SHIBUYA, M1 ; NIITANI, H2
[1] Nippon Medical School, Tokyo, Japan
[2] Nippon Medical School, Tokyo, Japan - Source
Anticancer research. 1995, Vol 15, Num 6B, pp 2691-2695 ; ref : 18 ref
- ISSN
- 0250-7005
- Scientific domain
- Medical oncology
- Publisher
- International Institute of Anticancer Research, Attiki
- Publication country
- Greece
- Document type
- Article
- Language
- English
- Keyword (fr)
- Anticancéreux Antimétabolite Association médicamenteuse Bronchopulmonaire Carcinome non petite cellule Chimiothérapie Cisplatine Homme Rythme administration Résultat Toxicité Traitement Tégafur Uracile Voie orale Appareil respiratoire pathologie Bronche pathologie Fluor Composé organique Platine II Complexe Poumon pathologie Pyrimidine nucléoside Tumeur maligne
- Keyword (en)
- Antineoplastic agent Antimetabolic Drug combination Bronchopulmonary Non small cell carcinoma Chemotherapy Human Administration schedule Result Toxicity Treatment Uracil Oral administration Respiratory disease Bronchus disease Fluorine Organic compounds Platinum II Complexes Lung disease Pyrimidine nucleoside Malignant tumor
- Keyword (es)
- Anticanceroso Antimetabólito Asociación medicamentosa Broncopulmonar Carcinoma no pequeña célula Quimioterapia Hombre Ritmo administración Resultado Toxicidad Tratamiento Uracilo Vía oral Aparato respiratorio patología Bronquio patología Fluor Compuesto orgánico Platino II Complejo Pulmón patología Pirimidina nucleósido Tumor maligno
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R02 Chemotherapy
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 3013693
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"6B\";s:8:\"\u0000*\u0000spage\";s:4:\"2691\";s:8:\"\u0000*\u0000epage\";s:4:\"2695\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GEMMA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:8:\"KUDOH, S\";i:1;s:12:\"YOSHIMURA, A\";i:2;s:6:\"ONO, Y\";i:3;s:11:\"TAKENAKA, K\";i:4;s:14:\"HAYASHIHARA, K\";i:5;s:7:\"HINO, M\";i:6;s:10:\"SHIBUYA, M\";i:7;s:10:\"NIITANI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"6B\";s:8:\"\u0000*\u0000spage\";s:4:\"2691\";s:8:\"\u0000*\u0000epage\";s:4:\"2695\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GEMMA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:8:\"KUDOH, S\";i:1;s:12:\"YOSHIMURA, A\";i:2;s:6:\"ONO, Y\";i:3;s:11:\"TAKENAKA, K\";i:4;s:14:\"HAYASHIHARA, K\";i:5;s:7:\"HINO, M\";i:6;s:10:\"SHIBUYA, M\";i:7;s:10:\"NIITANI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"6B\";s:8:\"\u0000*\u0000spage\";s:4:\"2691\";s:8:\"\u0000*\u0000epage\";s:4:\"2695\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GEMMA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:8:\"KUDOH, S\";i:1;s:12:\"YOSHIMURA, A\";i:2;s:6:\"ONO, Y\";i:3;s:11:\"TAKENAKA, K\";i:4;s:14:\"HAYASHIHARA, K\";i:5;s:7:\"HINO, M\";i:6;s:10:\"SHIBUYA, M\";i:7;s:10:\"NIITANI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"6B\";s:8:\"\u0000*\u0000spage\";s:4:\"2691\";s:8:\"\u0000*\u0000epage\";s:4:\"2695\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GEMMA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:8:\"KUDOH, S\";i:1;s:12:\"YOSHIMURA, A\";i:2;s:6:\"ONO, Y\";i:3;s:11:\"TAKENAKA, K\";i:4;s:14:\"HAYASHIHARA, K\";i:5;s:7:\"HINO, M\";i:6;s:10:\"SHIBUYA, M\";i:7;s:10:\"NIITANI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:9:\"\u0000*\u0000jtitle\";s:19:\"Anticancer research\";s:9:\"\u0000*\u0000stitle\";s:14:\"Anticancer res\";s:7:\"\u0000*\u0000date\";s:4:\"1995\";s:9:\"\u0000*\u0000volume\";s:2:\"15\";s:8:\"\u0000*\u0000issue\";s:2:\"6B\";s:8:\"\u0000*\u0000spage\";s:4:\"2691\";s:8:\"\u0000*\u0000epage\";s:4:\"2695\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0250-7005\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"GEMMA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"A\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:8:{i:0;s:8:\"KUDOH, S\";i:1;s:12:\"YOSHIMURA, A\";i:2;s:6:\"ONO, Y\";i:3;s:11:\"TAKENAKA, K\";i:4;s:14:\"HAYASHIHARA, K\";i:5;s:7:\"HINO, M\";i:6;s:10:\"SHIBUYA, M\";i:7;s:10:\"NIITANI, H\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:151:\"Pilot trial of a combination comprising of consecutive oral administration of UFT, and two-divided administration of CDDP in non-small cell lung cancer\";s:8:\"\u0000*\u0000place\";s:6:\"Attiki\";s:6:\"\u0000*\u0000pub\";s:46:\"International Institute of Anticancer Research\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
